Sugammadex Study First To Show Rapid Reversal Of Profound Rocuronium-Induced Muscle Relaxation Is Possible Schering-Plough Corp., (NYSE: SGP) announced that a study published in the November 2008 issue of the medical journal, Anesthesiology (Vol. 109, No. 5)(1) demonstrated that sugammadex produced a significantly more rapid recovery from profound rocuronium-induced muscle relaxation than the conventional reversal agent neostigmine.
Source: www.medicalnewstoday.com
# posted by Network @ 9:00 PM
